Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 16Myelodysplastic Syndromes 3Leukemia, Monocytic, Acute 3Leukemia 3Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Myeloproliferative Disorders 2Thrombocythemia, Essential 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Lymphoid 1Leukemia, Erythroblastic, Acute 1Leukemia, Biphenotypic, Acute 1Disease 1Congenital Abnormalities 1Burkitt Lymphoma 1

Interventions

Cytarabine 26Daunorubicin 11Mitoxantrone 7Idarubicin 7Etoposide 7fludarabine phosphate 6Filgrastim 6Busulfan 6Tacrolimus 5Peripheral Blood Stem Cell Transplantation 5Methotrexate 5Gemtuzumab 5Clofarabine 5tipifarnib 4alvocidib 4Vorinostat 4Decitabine 4Azacitidine 4sargramostim 3Whole-Body Irradiation 3Observation 3Mycophenolic Acid 3Granulocyte Colony-Stimulating Factor 3Bortezomib 3Biopsy 3Antilymphocyte Serum 3entinostat 2Sirolimus 2Pravastatin 2Flow Cytometry 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, Myelomonocytic, Acute × CPX-351 × Clear all
NCT02019069 2019-01-22

CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Stanford University

Phase 2 Completed
11 enrolled 17 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡